We are honored to announce Professor Giovanni Scambia’s appointment to Diatech Pharmacogenetics’s Scientific Board.
The Board is currently chaired by Stefano Pileri and composed of Reinhard Buettner, Bertrand Nadel, Riccardo Dalla-Favera, Raul Rabadan and Umberto Malapelle
A leading figure in gynaecological oncology, Prof. Scambia is the Scientific Director at Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Rome) and a Full Professor at the Catholic University (Rome).
With expertise in innovative cancer treatments and over 1500 publications, his leadership spans globally.
Prof. Scambia’s roles in prestigious organizations like the European Society for Gynaecological Endoscopy and his contributions to healthcare policy make him a valuable addition to our team.
Together, we’re committed to advancing personalized medicine and improving patient care worldwide.
Welcome, Professor Scambia!
